🇺🇸 FDA

Intelligence · Clinical Pipeline

First People's Hospital Pipeline

All ClinicalTrials.gov programs at First People's Hospital — phase, modality, and trial IDs.

Programs
186

Quick answer

First People's Hospital has 186 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Triple antithrombotic therapy

    The First People's Hospital of Lianyungang

    Acute Coronary Syndrome (ACS)

    approved small molecule active

    1 trial

  2. VAB-7

    The First People's Hospital of Lianyungang

    Helicobacter Pylori

    approved small molecule active

    1 trial

  3. Vancomycin

    The First People's Hospital of Lianyungang

    Blood Stream Infections

    approved small molecule active

    1 trial

  4. Vifor

    The First People's Hospital of Lianyungang

    Malnutrition

    approved small molecule completed

    1 trial

  5. Vonoprazan

    The First People's Hospital of Lianyungang

    Ulcers, Gastric

    approved small molecule active

    1 trial

  6. Vonoprazan

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    2 trials

  7. Vonoprazan and Amoxicillin for the first 7 days

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    1 trial

  8. Xingnaojing injection

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    1 trial

  9. Yiqitongluo granule

    The First People's Hospital of Lianyungang

    Stroke

    approved small molecule completed

    1 trial

  10. a control group

    The First People's Hospital of Lianyungang

    Disorder of Stomach Function and Feeding Problems in Newborn

    approved small molecule completed

    1 trial

  11. aspirin 100mg/d therapy

    The First People's Hospital of Lianyungang

    Coronary Atherosclerosis

    approved small molecule active

    1 trial

  12. aspirin and clopidogrel

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial

  13. berberine hydrochloride

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  14. butylphthalide(NBP)

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    approved small molecule completed

    1 trial

  15. dapagliflozin

    The First People's Hospital of Lianyungang

    Diabetic Kidney Disease

    approved small molecule active

    1 trial

  16. dexmedetomidine

    The First People's Hospital of Lianyungang

    Aged

    approved small molecule completed

    3 trials

  17. dexmedetomidine

    The First People's Hospital of Lianyungang

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  18. dexmedetomidine hydrochloride for injection

    The First People's Hospital of Lianyungang

    Delirium

    approved small molecule completed

    1 trial

  19. entecavir

    The First People's Hospital of Lianyungang

    Liver Fibrosis

    approved small molecule completed

    1 trial

  20. ginkgolide

    The First People's Hospital of Lianyungang

    Intravenous Alteplase Thrombolysis

    approved small molecule completed

    1 trial

  21. half-dose ticagrelor

    The First People's Hospital of Lianyungang

    Acute Coronary Syndrome

    approved small molecule active

    1 trial

  22. hydrochloride hydromorphone + flurbiprofen axetil

    The First People's Hospital of Lianyungang

    Enhanced Recovery After Surgery

    approved small molecule completed

    1 trial

  23. insulin lispro injection, exenatide injection

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  24. intravenous tranexamic acid (TXA) infusion

    The First People's Hospital of Lianyungang

    Spontaneous Intracranial Hemorrhage

    approved small molecule active

    1 trial

  25. iodixanol

    The First People's Hospital of Lianyungang

    Kidney Failure, Chronic

    approved small molecule active

    1 trial

  26. lorlatinib

    The First People's Hospital of Lianyungang

    NSCLC

    approved small molecule active

    1 trial

  27. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Platelet Reactivity

    approved small molecule completed

    1 trial

  28. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Coronary Artery Disease

    approved small molecule active

    1 trial

  29. minimally invasive cholecystolithotomy with gallbladder reservation

    The First People's Hospital of Lianyungang

    Gallstones

    approved other active

    1 trial

  30. mouse nerve growth factor

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Diseases

    approved small molecule active

    1 trial

  31. neoadjuvant therapy

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma Resectable

    approved other active

    1 trial

  32. prescribing anapproved drug, examination

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule active

    1 trial

  33. profound neuromuscular blockade

    The First People's Hospital of Lianyungang

    Profound Muscle Relaxation

    approved small molecule active

    1 trial

  34. quetiapine fumarate tablet (Seroquel)

    The First People's Hospital of Lianyungang

    Bipolar Disorder

    approved small molecule active

    1 trial

  35. rhGM-CSF group

    The First People's Hospital of Lianyungang

    Mycoses

    approved small molecule completed

    1 trial

  36. rhTPO

    The First People's Hospital of Lianyungang

    Primary Immune Thrombocytopenia

    approved small molecule active

    1 trial

  37. rhTPO

    The First People's Hospital of Lianyungang

    Thrombocytopenia

    approved small molecule active

    1 trial

  38. rituximab combined with corticosteroids

    The First People's Hospital of Lianyungang

    Primary Membranous Nephropathy

    approved small molecule active

    1 trial

  39. ropivacaine

    The First People's Hospital of Lianyungang

    Injury of Upper Limb

    approved small molecule completed

    1 trial

  40. semaglutide combined with metformin

    The First People's Hospital of Lianyungang

    Osteoporosis

    approved small molecule active

    1 trial

  41. sodium zirconium cyclic silicate

    The First People's Hospital of Lianyungang

    Potassium Imbalance

    approved small molecule active

    1 trial

  42. ticagrelor

    The First People's Hospital of Lianyungang

    Inflammation

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does First People's Hospital have?

186 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.